Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
Miele
L
L
Section on Developmental Genetics, NICHD, NIH, Bethesda, Maryland 20892.
Cordella-Miele
E
E
Facchiano
A
A
Mukherjee
A B
AB
D000595:Amino Acid Sequence; D000818:Animals; D017302:Annexins; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002135:Calcium-Binding Proteins / Q000737:chemistry / Q000494:pharmacology; D005260:Female; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D013329:Structure-Activity Relationship; D014598:Uteroglobin / Q000737:chemistry / Q000494:pharmacology*
D017302:Annexins; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002135:Calcium-Binding Proteins; D009842:Oligopeptides; D010446:Peptide Fragments; C064645:antiflammin P1; C064647:antiflammin P2; D014598:Uteroglobin; D010741:Phospholipases A; D054467:Phospholipases A2